Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Roche’s CARDIAC point-of-care Troponin T test now available to CE Mark accepting countries

Roche announced that its hand-held device CARDIAC point-of-care Troponin T test is available for countries accepting the CE Mark.

The test will enable healthcare workers to find out about patients with a suspected acute myocardial infarction (AMI) in 12 minutes.

Roche Diagnostics Division CEO Roland Diggelmann said: "Point-of-care diagnostics solutions play an integral role in an effective, sustainable healthcare, and their importance will further increase.

"The introduction of this improved test enables health care professionals to make earlier and more accurate interventions to save patients’ lives."

The point-of-care diagnostic system does not involve any lengthy setup procedures or sample preparation, which makes it easy to use in emergency cases.

After the test, result is determined, based on which high risk patients can be immediately sent directly to a cardiac catheterization laboratory, and patients with low risk can be sent to the hospital ward for further investigation.

The test is standardized and compatible with central lab testing, and the test can be combined with a later test using the Elecsys cardiac Troponin T high-sensitive (cTnT-hs) test.